• Article

Validation of a model to assess long-term disease progression in Alzheimer's disease patients treated with rivastigmine

Citation

Hauber, A., Candrilli, S., Snyder, EH., & McBurney, CR. (2004). Validation of a model to assess long-term disease progression in Alzheimer's disease patients treated with rivastigmine. Neurobiology of Aging, 25, S136-S136.